{"filing":{"accession_number":"0001193125-26-340409","cik":"0001832332","ticker":"AVAH","company_name":"Aveanna Healthcare Holdings, Inc.","form":"8-K","filing_date":"2026-08-07","report_date":"2026-08-05","primary_document":"avah-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1832332/000119312526340409/avah-20260805.htm"},"events":[{"id":25107,"run_id":22778,"accession_number":"0001193125-26-340409","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Dr. Erica Schwartz, a Class III independent director and Chair of the Clinical Quality Committee, resigned from Aveanna Healthcare's Board of Directors effective immediately on August 5, 2026, due to her nomination and confirmation as Director of the U.S. Centers for Disease Control and Prevention. This is a clear executive departure—the principal disclosed action is a director leaving the board. The resignation of a board chair, particularly one overseeing clinical quality at a healthcare company, is material to investors.","company_name":"Aveanna Healthcare Holdings, Inc.","ticker":"AVAH","filing_date":"2026-08-07","form":"8-K","submitted_at":null,"items":[{"id":25856,"accession_number":"0001193125-26-340409","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Dr. Erica Schwartz, a Class III independent director and Chair of the Clinical Quality Committee, resigned from Aveanna Healthcare's Board of Directors effective immediately on August 5, 2026, due to her nomination and confirmation as Director of the U.S. Centers for Disease Control and Prevention. This is a clear executive departure—the principal disclosed action is a director leaving the board. The resignation of a board chair, particularly one overseeing clinical quality at a healthcare company, is material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T00:27:37.175934+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25856,"accession_number":"0001193125-26-340409","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Dr. Erica Schwartz, a Class III independent director and Chair of the Clinical Quality Committee, resigned from Aveanna Healthcare's Board of Directors effective immediately on August 5, 2026, due to her nomination and confirmation as Director of the U.S. Centers for Disease Control and Prevention. This is a clear executive departure—the principal disclosed action is a director leaving the board. The resignation of a board chair, particularly one overseeing clinical quality at a healthcare company, is material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T00:27:37.175934+00:00","company_name":"Aveanna Healthcare Holdings, Inc.","ticker":"AVAH","filing_date":"2026-08-07"}]}